We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+7.33%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.44B
AUM Growth
+$259M
(+4.2%)
Cap. Flow
+$227M
Cap. Flow
% of AUM
3.52%
Top 10 Holdings %
Top 10 Hldgs %
34.31%
Holding
1,318
New
461
Increased
339
Reduced
236
Closed
232
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$330M |
| 2 |
Brookdale Senior Living
BKD
|
+$93.7M |
| 3 |
Tenet Healthcare
THC
|
+$85.2M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$70.6M |
| 5 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$64.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$206M |
| 2 |
CVS Health
CVS
|
+$122M |
| 3 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$102M |
| 4 |
McKesson
MCK
|
+$80.6M |
| 5 |
Pacira BioSciences
PCRX
|
+$45.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.08% |
| 2 | Miscellaneous | 9.89% |
| 3 | Energy | 6.47% |
| 4 | Consumer Discretionary | 5.67% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NBSE
126
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $10.5M | 0.16% |
+2,750
| New | +$10.4M |
|
|
SKX
127
DELISTED
Skechers
SKX
| $10.4M | 0.16% |
+681,423
| New | +$9.39M |
|
128
Eastman Chemical
EMN
$7.53B
| $10.3M | 0.16% |
118,390
+99,833
| +538% | +$8.67M |
|
129
Mettler-Toledo International
MTD
$26.7B
| $10.1M | 0.16% |
39,891
-37
| -0.1% | -$8.89K |
|
130
American International
AIG
$39.7B
| $10.1M | 0.16% |
184,739
+172,580
| +1,419% | +$9.14M |
|
131
Danaher
DHR
$147B
| $9.99M | 0.16% |
188,709
-13,011
| -6% | -$668K |
|
|
HCC
132
DELISTED
HCC INSURANCES HOLDINGS INC
HCC
| $9.81M | 0.15% |
+200,464
| New | +$9.34M |
|
133
Align Technology
ALGN
$10.4B
| $9.71M | 0.15% |
173,290
+13,064
| +8% | +$680K |
|
|
MWIV
134
DELISTED
MWI VETERINARY SUPPLY, INC.
MWIV
| $9.57M | 0.15% |
67,377
-5,445
| -7% | -$800K |
|
135
Veracyte
VCYT
$3.23B
| $9.52M | 0.15% |
556,000
-30,057
| -5% | -$433K |
|
|
AUY
136
DELISTED
Yamana Gold, Inc.
AUY
| $9.45M | 0.15% |
+1,150,000
| New | +$9.03M |
|
137
NRG Energy
NRG
$22.3B
| $9.34M | 0.15% |
251,093
+233,660
| +1,340% | +$8.04M |
|
|
NSTG
138
DELISTED
NanoString Technologies, Inc.
NSTG
| $9.21M | 0.14% |
615,800
+44,800
| +8% | +$706K |
|
139
Agilent Technologies
A
$42.4B
| $9.19M | 0.14% |
223,750
+148,921
| +199% | +$5.98M |
|
|
AGTC
140
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $9.07M | 0.14% |
+392,625
| New | +$6.92M |
|
|
SGI
141
Somnigroup International
SGI
$13.8B
| $9M | 0.14% |
603,192
+24,088
| +4% | +$323K |
|
|
FL
142
DELISTED
Foot Locker
FL
| $8.89M | 0.14% |
175,358
+25,096
| +17% | +$1.2M |
|
143
Accuray
ARAY
$27.5M
| $8.8M | 0.14% |
1,000,000
-450,000
| -31% | -$3.9M |
|
|
GHDX
144
DELISTED
Genomic Health, Inc.
GHDX
| $8.75M | 0.14% |
319,199
+12,241
| +4% | +$326K |
|
145
WEC Energy
WEC
$33.7B
| $8.7M | 0.14% |
+185,350
| New | +$8.61M |
|
|
HSH
146
DELISTED
HILLSHIRE BRANDS CO
HSH
| $8.69M | 0.14% |
+139,465
| New | +$6.3M |
|
147
Commerce Bancshares
CBSH
$8.39B
| $8.64M | 0.13% |
333,627
-69,995
| -17% | -$1.73M |
|
|
FRX
148
DELISTED
FOREST LABORATORIES INC
FRX
| $8.61M | 0.13% |
86,940
+602
| +0.7% | +$56.1K |
|
|
ATW
149
DELISTED
Atwood Oceanics
ATW
| $8.55M | 0.13% |
162,943
-7,503
| -4% | -$370K |
|
150
Trip.com Group
TCOM
$24.7B
| $8.54M | 0.13% |
+266,540
| New | +$7.19M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q2 2014 Portfolio in Review
As of Q2 2014, Visium Asset Management held 1,318 positions worth $6.44B, up 4.2% from $6.18B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Visium Asset Management deployed $227M of net new capital in Q2 2014, opening 461 new positions and adding to 339 existing holdings. Its largest new stake was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 56% a quarter earlier, followed by Miscellaneous and Energy.
On the sell side, the largest reduction was Bausch Health, an estimated $206M trimmed.
- Visium Asset Management's largest Q2 2014 buy was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.
- Visium Asset Management added most to Allergan Inc in Q2 2014, an estimated $330M increase.
- Visium Asset Management's biggest Q2 2014 reduction was Bausch Health, cutting an estimated $206M.
- Visium Asset Management fully exited QUESTCOR PHARMA INC in Q2 2014, selling an estimated $34M.
- Visium Asset Management's ten largest holdings make up 34% of its $6.44B portfolio in Q2 2014.
- Visium Asset Management opened 461 new positions and closed 232 in Q2 2014.
- Visium Asset Management's portfolio value rose 4.2% quarter-over-quarter to $6.44B.
Based on Visium Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.